AstraZeneca India to launch centres of excellence for severe asthma in Delhi, Ahmedabad, Kochi and Goa MD Bureau3 May 2023 1:30 PM ISTThe Centers of Excellence for severe asthma, as per the guidelines established by the Global Initiative for Asthma, would concentrate on specialty and...
Cipla arm gets zero Form 483 observations from USFDA for USA facility Ruchika Sharma3 May 2023 12:30 PM ISTMumbai: Cipla has recently announced that the US Food and Drug Administration has concluded inspection with zero Form 483 observations at the Fall...
Strides, Orbicular ink pact to develop range of nasal sprays Ruchika Sharma3 May 2023 11:30 AM ISTThe partnership will commercialize four nasal sprays with a combined Global IQVIA market size in excess of $400m.
Laurus Labs bags USFDA nod for Paediatric ARV Oral Dispersible Film drug Dolutegravir in HIV/AIDS treatment Ruchika Sharma2 May 2023 4:24 PM ISTHyderabad: Laurus Labs Ltd., a R&D driven pharmaceutical & biotech manufacturing company in India, has announced the receipt of the US Food...
Gilead Sciences, US square off in billion-dollar HIV drug patent trial Ruchika Sharma2 May 2023 3:46 PM ISTThe USFDA approved Gilead's Truvada for HIV prevention in 2012 and approved its related drug Descovy for the same purpose in 2019.
USFDA halts Sun Pharma trials on dermatological drug Deuruxolitinib Ruchika Sharma2 May 2023 2:46 PM ISTThe company said it would work closely with the FDA to address the agency's concerns, which the drugmaker expected to be communicated within the next...
Pfizer, Astellas Pharma' Xtandi combo therapy cuts risk of metastasis, death by 58 percent in prostate cancer Ruchika Sharma2 May 2023 12:30 PM ISTXTANDI (enzalutamide) is an androgen receptor signaling inhibitor.
Stryker raises profit forecast on stronger demand for surgical devices Ruchika Sharma2 May 2023 11:31 AM ISTUnited States: Medical technology company Stryker Corp on Monday raised its full-year profit forecast, citing stronger demand for the company's...
Bristol Myers Squibb gets USFDA priority review for expanded Reblozyl use Ruchika Sharma1 May 2023 5:31 PM ISTReblozyl, a first-in-class therapeutic option, promotes late-stage red blood cell maturation in animal models.
BioNTech , Pfizer propose EU pays half for each cancelled COVID dose: Report Ruchika Sharma1 May 2023 2:15 PM ISTBengaluru: Pfizer Inc and BioNTech's new proposal to the European Union, amid a glut of COVID-19 shots, includes a provision for member states to pay...
Abbott concludes acquisition of Cardiovascular Systems Ruchika Sharma1 May 2023 1:30 PM ISTAbbott Park, Ill: Abbott has announced it has completed the acquisition of Cardiovascular Systems, Inc. (CSI), a medical device company with an...
59 companies get land in upcoming medical device park near Noida Ruchika Sharma1 May 2023 12:30 PM IST"The list of medical devices that will be manufactured at the park is quite extensive and diverse," the official said.
